Trials / Conditions / Stable Coronary Artery Disease

Stable Coronary Artery Disease

25 registered clinical trials studyying Stable Coronary Artery Disease — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Coronary Laser Atherectomy Registry From an International Taskforce NCT07348341	Ceric Sàrl	—
Not Yet Recruiting	A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandocigu NCT07431294	Bayer	Phase 1
Recruiting	A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Hear NCT07495813	Hoffmann-La Roche	Phase 1
Terminated	Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis NCT07187895	Sinotau Pharmaceutical Group	Phase 2
Recruiting	MCG is Clinically Applied to Evaluate Myocardial Ischemic Function in Patients With Stable Coronary Artery Dis NCT06123728	Nanhai Hospital, Guangdong Provincial People's Hospital	—
Unknown	Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Diseas NCT04434365	Peking Union Medical College Hospital	Phase 1 / Phase 2
Completed	Precise Percutaneous Coronary Intervention Plan (P3) Study NCT03782688	Onze Lieve Vrouw Hospital	—
Completed	A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease NCT03384966	Viatris Innovation GmbH	Phase 2
Unknown	Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity NCT03313752	Andrea Giaccari	Phase 3
Completed	Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous NCT03312855	Deutsches Herzzentrum Muenchen	Phase 2
Unknown	To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent NCT03089450	CGBio Inc.	N/A
Completed	A Pharmacodynamic Study With Ticagrelor in Hispanic Patients NCT01523366	AstraZeneca	Phase 4
Completed	A Pharmacodynamic Study With Ticagrelor in African American Patients NCT01523392	AstraZeneca	Phase 4
Completed	Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention NCT02580851	University of Ulm	N/A
Completed	Prospective Study to Assess DES Re-endothelization in BMS Restenosis and De-novo Lesions NCT01243099	S.M. Misericordia Hospital	—
Completed	ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation NCT01184300	Ottawa Heart Institute Research Corporation	Phase 2 / Phase 3
Completed	An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Dise NCT01118325	AstraZeneca	Phase 2
Completed	Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable CAD NCT01209637	University of Leipzig	N/A
Completed	Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy NCT00984802	Ischemix, LLC	Phase 2
Unknown	Prognostic Models for People With Stable Coronary Artery Disease NCT01609465	University College, London	—
Completed	Computed Tomography Coronary Angiography Before Stent Implantation NCT01205425	National Institute of Cardiology, Warsaw, Poland	N/A
Terminated	Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery D NCT00911339	Fondazione IRCCS Policlinico San Matteo di Pavia	Phase 3
Completed	A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder NCT00642811	AstraZeneca	Phase 2
Completed	Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease NCT00510588	University of Leipzig	N/A
Completed	Cardiovascular Events Related to Treated Coronary Arteries in Stable Multivessel CAD NCT07362108	Instituto do Coracao	—